Literature DB >> 9582124

Requirement for Atm in ionizing radiation-induced cell death in the developing central nervous system.

K H Herzog1, M J Chong, M Kapsetaki, J I Morgan, P J McKinnon.   

Abstract

Ataxia telangiectasia (AT) is characterized by progressive neurodegeneration that results from mutation of the ATM gene. However, neither the normal function of ATM in the nervous system nor the biological basis of the degeneration in AT is known. Resistance to apoptosis in the developing central nervous system (CNS) of Atm-/- mice was observed after ionizing radiation. This lack of death occurred in diverse regions of the CNS, including the cerebellum, which is markedly affected in AT. In wild-type, but not Atm-/- mice, up-regulation of p53 coincided with cell death, suggesting that Atm-dependent apoptosis in the CNS is mediated by p53. Further, p53 null mice showed a similar lack of radiation-induced cell death in the developing nervous system. Atm may function at a developmental survival checkpoint that serves to eliminate neurons with excessive DNA damage.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9582124     DOI: 10.1126/science.280.5366.1089

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  138 in total

Review 1.  The pathogenesis of ataxia-telangiectasia. Learning from a Rosetta Stone.

Authors:  R A Gatti; S Becker-Catania; H H Chun; X Sun; M Mitui; C H Lai; N Khanlou; M Babaei; R Cheng; C Clark; Y Huo; N C Udar; R K Iyer
Journal:  Clin Rev Allergy Immunol       Date:  2001-02       Impact factor: 8.667

2.  DNA repair on the brain.

Authors:  R R Laposa; J E Cleaver
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-06       Impact factor: 11.205

Review 3.  p53-dependent cell death signaling in neurons.

Authors:  Richard S Morrison; Yoshito Kinoshita; Mark D Johnson; Weiqun Guo; Gwenn A Garden
Journal:  Neurochem Res       Date:  2003-01       Impact factor: 3.996

4.  Mitochondrial dysfunction in ataxia-telangiectasia.

Authors:  Yasmine A Valentin-Vega; Kirsteen H Maclean; Jacqueline Tait-Mulder; Sandra Milasta; Meredith Steeves; Frank C Dorsey; John L Cleveland; Douglas R Green; Michael B Kastan
Journal:  Blood       Date:  2011-12-05       Impact factor: 22.113

Review 5.  Emerging role of the MORF/MRG gene family in various biological processes, including aging.

Authors:  Meizhen Chen; Kaoru Tominaga; Olivia M Pereira-Smith
Journal:  Ann N Y Acad Sci       Date:  2010-06       Impact factor: 5.691

6.  Nucleolar disruption and apoptosis are distinct neuronal responses to etoposide-induced DNA damage.

Authors:  Maciej Pietrzak; Scott C Smith; Justin T Geralds; Theo Hagg; Cynthia Gomes; Michal Hetman
Journal:  J Neurochem       Date:  2011-05-13       Impact factor: 5.372

7.  Chk2 is dispensable for p53-mediated G1 arrest but is required for a latent p53-mediated apoptotic response.

Authors:  Melissa T Jack; Richard A Woo; Atsushi Hirao; Alison Cheung; Tak W Mak; Patrick W K Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-03       Impact factor: 11.205

8.  Differential DNA damage signaling accounts for distinct neural apoptotic responses in ATLD and NBS.

Authors:  Erin R P Shull; Youngsoo Lee; Hironobu Nakane; Travis H Stracker; Jingfeng Zhao; Helen R Russell; John H J Petrini; Peter J McKinnon
Journal:  Genes Dev       Date:  2009-01-15       Impact factor: 11.361

Review 9.  Chronic oxidative damage together with genome repair deficiency in the neurons is a double whammy for neurodegeneration: Is damage response signaling a potential therapeutic target?

Authors:  Haibo Wang; Prakash Dharmalingam; Velmarini Vasquez; Joy Mitra; Istvan Boldogh; K S Rao; Thomas A Kent; Sankar Mitra; Muralidhar L Hegde
Journal:  Mech Ageing Dev       Date:  2016-09-20       Impact factor: 5.432

Review 10.  DNA damage and tissue repair: What we can learn from planaria.

Authors:  Paul G Barghouth; Manish Thiruvalluvan; Melanie LeGro; Néstor J Oviedo
Journal:  Semin Cell Dev Biol       Date:  2018-05-03       Impact factor: 7.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.